This vaccine helps prevent:
The Tdap vaccine contains diphtheria and tetanus toxoids, and small pieces of inactive pertussis bacteria.
It is given to children 7 years and older and to adults to protect against tetanus, diphtheria, and pertussis infections.
The vaccine is given as an injection, usually into the arm or thigh.
Tdap is routinely recommended for children aged 11 years or older, regardless of whether or not they completed the DTaP series. Tdap can also be given to:
If you or your child have not been fully vaccinated against tetanus, diphtheria, and pertussis, talk to the doctor.
Most people tolerate the vaccines without any trouble. The most common side effects are:
Uncommon symptoms include:
Acetaminophen is sometimes given to reduce pain and fever that may occur after getting a vaccine. In infants, the medication may weaken the vaccine's effectiveness. However, in children at risk for seizures, a fever-lowering medication may be important to take. Discuss the risks and benefits of taking acetaminophen with your doctor.
Most people should receive their vaccinations on schedule. However, individuals in whom the risks of vaccination outweigh the benefits include people who:
Talk with your doctor before getting the vaccine if you have:
The best way to prevent diphtheria is to get vaccinated.
Promptly clean all wounds and follow up with your doctor for medical care to prevent a tetanus infection.
You can help prevent pertussis by keeping infants and other people at high risk away from infected people.
In the event of a pertussis outbreak, all people who may have been exposed should be brought up to date with the vaccination. It is important to protect infants by isolating those who have the infection. Diagnosing the disease as quickly as possible can help control future outbreaks.
WHERE CAN I GET MORE INFORMATION?
Centers for Disease Control and Prevention
Healthy Children—American Academy of Pediatrics
Centers for Disease Control and Prevention. FDA approval of expanded age indication for a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. MMWR Morb Mortal Wkly Rep. 2011;60(37):1279-1280.
Fisman DN, Tang P, et al. Pertussis resurgence in Toronto, Canada: a population-based study including test-incidence feedback modeling. BMC Public Health. 2011;11:694.
Friedrich MJ. Research aims to boost pertussis control. JAMA. 2011;306(1):27-29.
Pertussis (whooping cough) vaccination. Centers for Disease Control and Prevention, National Immunization Program website. Available at: http://www.cdc.gov/vaccines/vpd-vac/pertussis/default.htm. Updated February 3, 2016. Accessed June 7, 2016.
Recommended immunization schedule for adults. Centers for Disease Control and Prevention website. Available at: https://www.cdc.gov/vaccines/schedules/hcp/adult.html. Published February 6, 2017. Accessed February 9, 2017.
Recommended immunization schedule for children and adolescents aged 18 years or younger. Centers for Disease Control and Prevention website. Available at: https://www.cdc.gov/vaccines/schedules/hcp/child-adolescent.html. Published February 6, 2017. Accessed February 8, 2017.
Tdap vaccine: what you need to know. Centers for Disease Control and Prevention website. Available at: http://www.cdc.gov/vaccines/hcp/vis/vis-statements/tdap.pdf. Updated February 24, 2015. Accessed June 7, 2016.
Vaccinations for adults. Immunization Action Coalition website. Available at: http://www.immunize.org/catg.d/p4030.pdf. Updated March 2016. Accessed June 7, 2016.
10/30/2009 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Prymula R, Siegrist C, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet. 2009;374(9698):1339.
11/4/2011 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months—Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1424-1426.
Last reviewed June 2016 by Marcie Sidman, MD Last Updated: 2/8/2017